Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:41 PM
Ignite Modification Date:
2025-12-24 @ 7:41 PM
NCT ID:
NCT05802303
Eligibility Criteria:
Inclusion Criteria:
* Infertile patients aged 23-35 years.
* BMI 18.5 to 29.9 kg/m2.
* A normal uterine cavity assessed by 3D ultrasound (USG)/hysteroscopy.
* Patients who underwent IVF/ICSI and who have cryopreserved their embryos.
* Those receiving donor oocytes or donor embryos.
* Patients undergoing hormonal replacement frozen embryo transfer (HRT-FET) cycles with GnRH agonist suppression.
* Embryo Transfers of good quality embryos -2/3/4/5 AA, AB, BA(As per Gardner Grading System).
Exclusion Criteria:
* Preimplantation Genetic Testing for Aneuploidies (PGT-A) cycles.
* Patients who had a FET performed in natural or stimulated cycles.
* Patients who had more than 2 failed transfers due to thin endometrium.
* Patients having uterine anomalies.
* Known cases of adenomyosis and endometriosis.
* Underlying cardiac/renal/hepatic/thromboembolic disorders, h/o anxiety or depression.
* E2 \>50 pg./ml, P4 \> 1 ng/ml and on D2 of menses.
* On D2 scan presence of a cyst or a dominant follicle.
* Patients with a history of recurrent 1st-trimester abortions.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
25 Years
Maximum Age:
35 Years
Study:
NCT05802303
Study Brief:
Protocol Section:
NCT05802303